
Latent autoimmune diabetes in adults (LADA) is a disorder with onset after age 30, insulin independence for at least 6 months after diagnosis, and the presence of circulating pancreatic islet autoantibodies. The prevalence of LADA varies substantially across ethnic groups and ranges approximately from 1% to 10% among patients with type 2 diabetes. In this review we discuss the nomenclature, diagnostic criteria, immunologic and genetic markers, metabolic alterations and therapy of this form of diabetes.
Adult, Autoimmunity, Autoimmune Diseases, Diagnosis, Differential, Islets of Langerhans, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Terminology as Topic, Diabetes Mellitus, Prevalence, Humans, Age of Onset, Biomarkers, Autoantibodies
Adult, Autoimmunity, Autoimmune Diseases, Diagnosis, Differential, Islets of Langerhans, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Terminology as Topic, Diabetes Mellitus, Prevalence, Humans, Age of Onset, Biomarkers, Autoantibodies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
